TY - JOUR
T1 - Errors in determination of net survival
T2 - cause-specific and relative survival settings
AU - Bright, Chloe J.
AU - Brentnall, Adam R.
AU - Wooldrage, Kate
AU - Myles, Jonathon
AU - Sasieni, Peter
AU - Duffy, Stephen W.
N1 - Publisher Copyright:
© 2020, Crown.
PY - 2020/3/31
Y1 - 2020/3/31
N2 - Background: Cause-specific and relative survival estimates differ. We aimed to examine these differences in common cancers where by possible identifying the most plausible sources of error in each estimate. Methods: Ten-year cause-specific and relative survival were estimated for lung, breast, prostate, ovary, oesophagus and colorectal cancers. The cause-specific survival was corrected for misclassification of cause of death. The Pohar-Perme relative survival estimator was modified by (1) correcting for differences in deaths from ischaemic heart disease (IHD) between cancers and general population; or (2) correcting the population hazard for smoking (lung cancer only). Results: For all cancers except breast and prostate, relative survival was lower than cause-specific. Correction for published error rates in cause of death gave implausible results. Correction for rates of IHD death gave slightly different relative survival estimates for lung, oesophagus and colorectal cancers. For lung cancer, when the population hazard was inflated for smoking, survival estimates were increased. Conclusion: Results agreed with the consensus that relative survival is usually preferable. However, for some cancers, relative survival might be inaccurate (e.g. lung and prostate). Likely solutions include enhancing life tables to include other demographic variables than age and sex, and to stratify relative survival calculation by cause of death.
AB - Background: Cause-specific and relative survival estimates differ. We aimed to examine these differences in common cancers where by possible identifying the most plausible sources of error in each estimate. Methods: Ten-year cause-specific and relative survival were estimated for lung, breast, prostate, ovary, oesophagus and colorectal cancers. The cause-specific survival was corrected for misclassification of cause of death. The Pohar-Perme relative survival estimator was modified by (1) correcting for differences in deaths from ischaemic heart disease (IHD) between cancers and general population; or (2) correcting the population hazard for smoking (lung cancer only). Results: For all cancers except breast and prostate, relative survival was lower than cause-specific. Correction for published error rates in cause of death gave implausible results. Correction for rates of IHD death gave slightly different relative survival estimates for lung, oesophagus and colorectal cancers. For lung cancer, when the population hazard was inflated for smoking, survival estimates were increased. Conclusion: Results agreed with the consensus that relative survival is usually preferable. However, for some cancers, relative survival might be inaccurate (e.g. lung and prostate). Likely solutions include enhancing life tables to include other demographic variables than age and sex, and to stratify relative survival calculation by cause of death.
UR - https://www.scopus.com/pages/publications/85079194410
U2 - 10.1038/s41416-020-0739-4
DO - 10.1038/s41416-020-0739-4
M3 - Article
C2 - 32037401
AN - SCOPUS:85079194410
SN - 0007-0920
VL - 122
SP - 1094
EP - 1101
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 7
ER -